In vitro effects of non-steroidal anti-inflammatory drugs on cytokine, prostanoid and matrix metalloproteinase production by interface membranes from loose hip or knee endoprostheses

Osteoarthritis and Cartilage

Volumn 15, Issue 5, 2007, Pages 531-542

  Syggelos, S A ^a   Giannopoulou, E ^a   Gouvousis, P A ^b   Andonopoulos, A P ^c   Aletras, A J ^b   Panagiotopoulos, E ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b School of Health Sciences   (Greece)

^c UNIVERSITY OF PATRAS   (Greece)

Author keywords

Arthroplasty; Cytokines; Matrix metalloproteinases; Non steroidal anti inflammatory drugs; Periprosthetic loosening; Tissue inhibitors of matrix metalloproteinases

Indexed keywords

ACECLOFENAC; COLLAGENASE 3; CYTOKINE; GELATINASE; GELATINASE A; GELATINASE B; INDOMETACIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PIROXICAM; PROSTAGLANDIN E2; STROMELYSIN; TENOXICAM; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOPROSTHESIS LOOSENING; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SYNTHESIS; FEMALE; GEL MOBILITY SHIFT ASSAY; HIP OSTEOARTHRITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INHIBITION KINETICS; KNEE OSTEOARTHRITIS; MICROBIOLOGICAL EXAMINATION; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; REOPERATION; TISSUE CULTURE; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; CYTOKINES; DICLOFENAC; DINOPROSTONE; FEMALE; HIP PROSTHESIS; HUMANS; INDOMETHACIN; KNEE PROSTHESIS; MATRIX METALLOPROTEINASES; MIDDLE AGED; PIROXICAM; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 34247555973     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2006.11.003     Document Type: Article

References (58)

1. Takagi M. Neutral proteinases and their inhibitors in the loosening of total hip prostheses. Acta Orthop Scand 271 Suppl (1996) 3-29
2. Archibeck M.J., Jacobs J.J., Roebuck K.A., and Glant T.T. The basic science of periprosthetic osteolysis. J Bone Joint Surg 82-A (2000) 1478-1489
3. Schmalzried T.P., and Gallaghan J.J. Wear in total hip and knee replacements. J Bone Joint Surg 81-A (1999) 115-136
4. Hirakawa K., Bauer T., Stulberg B.N., and Wilde A.H. Comparison and quantitation of wear debris of failed total hip and total knee arthroplasty. J Biomed Mater Res 31 (1996) 257-263
5. Maloney W.J., Smith R.L., Schmalzried T.P., Chiba J., Huene D., and Rubash H. Isolation and characterization of wear particles generated in patients who have had failure of a hip arthroplasty without cement. J Bone Joint Surg 77-A (1995) 1301-1310
6. Jiranek W.A., Machado M., Jasty M., Jevsevar D., Wolfe H.J., Goldring S.R., et al. Production of cytokines around loosened cemented acetabular components. Analysis with immunohistochemical techniques and in situ hybridization. J Bone Joint Surg 75-A (1993) 863-879
7. Chiba J., Rubash H., Kim K., and Iwaki Y. The characterization of cytokines in the interface tissue obtained from failed cementless total hip arthroplasty with and without femoral osteolysis. Clin Orthop Rel Res 300 (1994) 304-312
8. Takagi M., Konttinen Y.T., Santavira S., Sorsa T., Eisen A.Z., and Nordsletten I. Extracellular matrix metalloproteinases around loose total hip prostheses. Acta Orthop Scand 65 (1994) 281-286
9. Goldberg G.I., Wilhelm S.M., Kronberger A., Bauer E.A., Grant G.A., and Eisen A.Z. Human fibroblast collagenase. J Biol Chem 261 (1986) 6600-6605
10. Hasty K.A., Jeffrey J.J., Hibbs M.S., and Welgus H.G. The collagen substrate specificity of human neutrophil collagenase. J Biol Chem 262 (1987) 10048-10052
11. Knauper V., Lopez-Otin C., Smith B., Knight G., and Murphy G. Biochemical characterization of human collagenase-3. J Biol Chem 271 (1996) 1544-1550
12. Chambers T.J., Darby J.A., and Fuller K. Mammalian collagenase predispose bone surfaces to osteoclastic resorption. Cell Tissue Res 241 (1985) 671-675
13. Takagi M., Konttinen Y.T., Kemppinen P., Sorsa T., Tschesche H., Blaser J., et al. Tissue inhibitor of metalloproteinase 1, collagenolytic and gelatinolytic activity in loose hip endoprostheses. J Rheumatol 22 (1995) 2285-2290
14. Syggelos S.A., Eleftheriou S.C., Giannopoulou E., Panagiotopoulos E., and Aletras A.J. Gelatinolytic and collagenolytic activity in periprosthetic tissues from loose hip endoprostheses. J Rheumatol 28 (2001) 1319-1329
15. Gowen M., Wood D.D., Ihrie E.J., McGuire M.K.B., and Russell R.G.G. An interleukin-1-like factor stimulates bone resorption in vitro. Nature 306 (1983) 378-380
16. Akatsu T., Takahashi N., Udagawa N., Imamura K., Yamaguchi A., Sato K., et al. Role of prostaglandins in interleukin-1-induced bone resorption in mice in vitro. J Bone Miner Res 6 (1991) 183-190
17. Goodman S.B., Chin R.C., Chiou S.S., Schurman D.J., Woolson S.T., and Masada M.P. A clinical-pathologic-biochemical study of the membrane surrounding loosened and nonloosened total hip arthroplasties. Clin Orthop 244 (1989) 182-187
18. Kusano K., Miyaura C., Inada M., Tamura T., Ito A., Nagase H., et al. Regulation of metalloproteinases (MMP-2, -3, -9 and -13) by interleukin-1 and interleukin-6 in mouse calvaria: association of MMP induction with bone resorption. Endocrinology 139 (1998) 1338-1345
19. Ishimi Y., Miyaura C., Jin C.H., Akatsu T., Abe E., Nakamura Y., et al. IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 145 (1990) 3297-3303
20. Kurihara N., Bertolini D., Suda T., Akiyama Y., and Roodman G.D. IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release. J Immunol 144 (1990) 4226-4230
21. Lerner U.H., and Ohlin A. Tumor necrosis factor alpha and beta can stimulate bone resorption in cultured mouse calvaria by a prostaglandin-independent mechanism. J Bone Miner Res 2 (1993) 147-155
22. Horowitz S.M., and Purdon M.A. Mediator interactions in macrophage/particulate bone resorption. J Biomed Mater Res 29 (1995) 477-484
23. Takei H., Pioletti D., Kwon S.Y., and Sung P. Combined effect of titanium particles and TNF-α on the production of IL-6 by osteoblast-like cells. J Biomed Mater Res 52 (2000) 382-387
24. Goldring S.R., Jasty M., Roelke M.S., Rourke C.M., Bringhurst F.R., and Harris W.H. Formation of a synovial-like membrane at the bone-cement interface. Its role in bone resorption and implant loosening after total hip replacement. Arthritis Rheum 29 (1986) 836-841
25. Appel A.M., Sowder W.G., Siverhus S.W., Hopson C.N., and Herman J.H. Prosthesis-associated pseudomembrane-induced bone resorption. Br J Rheumatol 29 (1990) 32-36
26. Herman J.H., Sowder W.G., and Hess E.V. Nonsteroidal antiinflammatory drug modulation of prosthesis pseudomembrane induced bone resorption. J Rheumatol 21 (1994) 338-343
27. Ohlin A., and Lerner U.H. Bone-resorbing activity of different periprosthetic tissues in aseptic loosening of total hip arthroplasty. Bone Miner 20 (1993) 67-78
28. Ito A., Nose T., Takahashi S., and Mori Y. Cyclooxygenase inhibitors augment the production of pro-matrix metalloproteinase-9 (progelatinase B) in rabbit articular chondrocytes. FEBS Lett 360 (1995) 75-79
29. 1 inhibit cytokine-induced metalloprotease expression in human synovial fibroblasts. Mediation by cyclic-AMP signaling pathway. Lab Invest 71 (1994) 270-278
30. Takahashi S., Inoue T., Higaki M., and Mizushima Y. Cyclooxygenase inhibitors enhance the production of tissue inhibitor-1 of metalloproteinases (TIMP-1) and pro-matrix metalloproteinase-1 (proMMP-1) in human rheumatoid synovial fibroblasts. Inflamm Res 46 (1997) 320-323
31. Lin S.K., Wang C.C., Huang S., Lee J.J., Chiang C.P., Lan W.H., et al. Induction of dental pulp fibroblast matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 gene expression by interleukin-1α and tumor necrosis factor-α through a prostaglandin-dependent pathway. J Endod 27 (2001) 185-189
32. Yamazaki R., Kawai S., Mizushima Y., Matsuzaki T., Hashimoto S., Yokokura T., et al. A major metabolite of aceclofenac, 4′-hydroxy aceclofenac, suppresses the production of interstitial pro-collagenase/proMMP-1 and pro-stromelysin-1/proMMP-3 by human rheumatoid synovial cells. Inflamm Res 49 (2000) 133-138
33. Akimoto H., Yamazaki R., Hashimoto S., Sato T., and Ito A. 4′-Hydroxy aceclofenac, suppresses the interleukin-1-induced production of promatrix metalloproteinases and release of sulfated-glycosaminoglycans from rabbit articular chondrocytes. Eur J Pharmacol 401 (2000) 429-436
34. Dingle J.T. The effect of NSAIDs on human articular cartilage glycosaminoglycan synthesis. Eur J Rheum Inflamm 16 (1996) 47-52
35. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
36. Velleman S.G. Quantifying immunoblots with a digital scanner. Biotechniques 18 (1995) 1056-1058
37. Murphy G., Koklitis P., and Carne A.F. Dissociation of tissue inhibitor of metalloproteinases (TIMP) from enzyme complexes yields fully active inhibitor. Biochem J 261 (1989) 1031-1034
38. 2, and production of interleukins 1, 6 and 8, in human and porcine explants in organ culture. J Pharm Pharmacol 49 (1997) 991-998
39. Sanchez C., Mateus M.M., Defresne M.P., Crielaard J.M., Reginster J.Y., and Henrotin Y.E. Metabolism of human articular chondrocytes cultured in alginate beads. Long term effects of interleukin-1beta and nonsteroidal anti-inflammatory drugs. J Rheumatol 29 (2002) 772-782
40. 2 enhances interleukin-8 (IL-8) and IL-6 but inhibits GMCSF production by IL-1 stimulated human synovial fibroblasts in vitro. J Rheumatol 23 (1996) 862-868
41. 2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo. J Exp Med 184 (1996) 883-891
42. Watanabe-Tonita Y., Suzuki A., Oiso Y., and Kozawa O. Prostaglandin E1 stimulates interleukin-6 secretion via protein kinase A in osteoblast-like cells. Cell Signal 8 (1997) 711-715
43. Kozawa O., Suzuki A., Tokuda H., Kaida T., and Uematsu T. Interleukin-6 synthesis induced by prostaglandin E2: cross-talk regulation by protein-kinase C. Bone 22 (1998) 355-360
44. Kurihara Y., Endo H., and Kondo H. Induction of IL-6 via the EP3 subtype of prostaglandin E receptor in rat adjuvant-arthritic synovial cells. Inflamm Res 50 (2001) 1-5
45. 2 of the production of interleukin-6, macrophage colony stimulating factor, and vascular endothelial growth factor in human synovial fibroblasts. Br J Pharmacol 136 (2002) 287-295
46. Martel-Pelletier J., Cloutier J.M., and Pelletier J.P. Effects of aceclofenac and diclofenac on synovial inflammatory factors in human osteoarthritis. Pharmacodynamics 14 (1997) 226-232
47. Shield M.J. Misoprostol: new frontiers; benefits beyond the gastrointestinal tract. Scand J Rheumatol 92 Suppl (1992) 31-52
48. Kunkel S.L., and Chensue S.W. Arachidonic acid metabolites regulate IL-1 production. Biochem Biophys Res Commun 128 (1985) 892-897
49. Gonzalez E., de la Cruz C., de Nicolas R., Egido J., and Herrero-Beaumont G. Long-term effect of nonsteroidal anti-inflammatory drugs on the production of cytokines and other inflammatory mediators by blood cells of patients with osteoarthritis. Agents Actions 41 (1994) 171-178
50. Zhang Y., McCluskey K., Fujli K., and Wahl L.M. Differential regulation of monocyte matrix MMP and TIMP-1 production by TNF-α, granulocyte-macrophage CSF and IL-1β through prostaglandin-dependent and independent mechanisms. J Immunol 161 (1998) 3071-3076
51. Konntinen Y.T., Waris V., Xu J.W., Jiranek W.A., Sorsa T., Virtanen I., et al. Transforming growth factor-beta 1 and 2 in the synovial-like interface membrane between implant and bone in loosening of total hip arthroplasty. J Rheumatol 24 (1997) 694-701
52. Wright J.K., Cawston T.E., and Hazleman B.L. TGF-β stimulates the production of TIMP by human synovial and skin fibroblasts. Biochim Biophys Acta 1094 (1991) 207-210
53. Mauviel A., Chung K.Y., Agarwal A., Tamai K., and Uitto J. Cell-specific induction of distinct oncogenes of the Jun family is responsible for differential regulation of collagenase gene expression by transforming growth factor-beta in fibroblasts and keratinocytes. J Biol Chem 271 (1996) 10917-10923
54. Yuan W., and Varga J. Transforming growth factor-β repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3. J Biol Chem 276 (2001) 38502-38510
55. 2 in human synovial fibroblasts. J Cell Biochem 57 (1995) 619-629
56. Hill P.A., Reynolds J.J., and Meikle M.C. Inhibition of stimulated bone resorption in vitro by TIMP-1 and TIMP-2. Biochim Biophys Acta 1177 (1993) 71-74
57. Hill P.A., Murphy G., Docherty A.J., Hembry R.M., Millican T.A., Reynolds J.J., et al. The effects of selective inhibitors of matrix metalloproteinases (MMPs) on bone resorption and the identification of MMPs and TIMP-1 in isolated osteoclasts. J Cell Sci 107 (1994) 3055-3064
58. Hill P.A., Docherty A.J., Bottomley K.M., O' Connell J.P., Murphy G., Reynolds J.J., et al. Inhibition of bone resorption in vitro by selective inhibitors of gelatinase and collagenase. Biochem J 308 (1995) 167-175